Efficacy of the novel Plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial

類似資料

• Safety and immunogenicity of the novel plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial
  著者:: Minassian, AM, 等
  出版事項: (2017)
• Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
  著者:: Minassian, AM, 等
  出版事項: (2021)
• Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured onthe AGE1.CR.pIX Avian Cell Line
  著者:: Folegatti, P, 等
  出版事項: (2019)
• In silico T cell epitope prediction identifies high value RH5 epitopes that correlate with response in vaccinees
  著者:: Terry, F, 等
  出版事項: (2018)
• Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
  著者:: Folegatti, PM, 等
  出版事項: (2020)